Key Safety Considerations Before Any Switch Thyroid C-Cell Risk Both dulaglutide and retatrutide carry a class warning for thyroid C-cell tumors based on rodent studies [14]
In the Yale study, researchers tested once-weekly injections of 1 mg, 4 mg, 8 mg, and 12 mg for 48 weeks
Gallbladder Disease and Pancreatitis Gallbladder problems, including gallstones, have been associated with significant weight loss and with GLP-1-based therapies more broadly
Participants were assessed at baseline (prior to GLP-1RA initiation), 3 months, and 12 months post-initiation
If you're thinking about incorporating another treatment, it's essential to consult a licensed healthcare provider
It often requires long-term management, which may include ongoing medication